Pharmaceutical companies cannot demand the popular antidepressant Zoloft, as it was massively sold out against the backdrop of the COVID-19 pandemic.
The Food and Drug Administration reports a shortage of antidepressant drugs, as more people are getting prescriptions from doctors and there are not enough ingredients to make new batches. His generics are also in short supply.
A number of drug manufacturers experience difficulties in meeting increased demand when it is not possible to obtain all the necessary components.
According to Bloomberg, in March alone, the number of people willing to buy Zoloft grew by 12% compared with the same month last year.